drugset / Trial / NCT00004479

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

NCT00004479

RandomizedDouble-blindTreatment

Summary

OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.

Timeline

Start
1999-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule

Indications

No indication recorded.